$LYCA SEC Filings

Filed On	Filing
26 Oct 2026	Form 4: Touami Sofia, Chief Business Officer Granted 68,755 Stock Option (Right to Buy)
26 Oct 2026	Form 4: Staben Steven, Chief Scientific Officer Granted 110,896 Stock Option (Right to Buy)
26 Oct 2026	Form 4: Bachrodt Amy, Chief Financial Officer Granted 399,746 Stock Option (Right to Buy)
26 Oct 2026	Form 4: Lee Chin Hyok, Chief Medical Officer Granted 73,191 Stock Option (Right to Buy)
26 Oct 2026	Form 4: Trombley Aetna Wun, Director Granted 443,586 Stock Option (Right to Buy)
26 Oct 2026	Form 4: Henderson Jane, Director Granted 57,666 Stock Option (Right to Buy) · Granted 20,000 Stock Option (Right to Buy)
26 Oct 2026	Form 4: Fischer Laurent, Director Granted 13,307 Stock Option (Right to Buy) · Granted 20,000 Stock Option (Right to Buy)
26 Oct 2026	Form 4: Rieflin William Jl, Director Granted 24,840 Stock Option (Right to Buy) · Granted 20,000 Stock Option (Right to Buy)
26 Oct 2026	8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
23 Oct 2026	S-8
23 Oct 2026	424B4
22 Oct 2026	Form 3: Touami Sofia, Chief Business Officer
22 Oct 2026	Form 3: Staben Steven, Chief Scientific Officer Holds 55,448 shares of Common Stock
22 Oct 2026	Form 3: Bachrodt Amy, Chief Financial Officer
22 Oct 2026	Form 3: Lee Chin Hyok, Chief Medical Officer
22 Oct 2026	Form 3: Trombley Aetna Wun, Director Holds 415,255 shares of Common Stock
22 Oct 2026	Form 3: Bertozzi Carolyn R, 10% owner Holds 904,821 shares of Common Stock
22 Oct 2026	Form 3: Henderson Jane, Director
22 Oct 2026	Form 3: Fischer Laurent, Director Holds 33,269 shares of Common Stock
22 Oct 2026	Form 3: Venrock Healthcare Capital Partners III, L.p., 10% owner and 8 others

Comments